Close Menu

NEW YORK (360Dx) – OraSure Technologies reported a 31 percent year-over-year increase in its third quarter revenues, including a 186 percent rise in hepatitis C revenues.

For the three months ended Sept. 30, total revenues grew to $42.3 million from $32.3 million in Q3 2016. It beat the consensus Wall Street estimate of $40.8 million.

HCV testing revenues rose to $8.0 million from $2.8 million, while HIV testing revenues were up 13 percent year over year to $8.2 million from $7.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.